ÌìÃÀÓ°Ôº

This report should be read in conjunction with the full KPI data tables published each quarter.

1. Fetal anomaly screening

1.1 KPI FA2: coverage: fetal anomaly ultrasound

National performance of FA2 (see ²õ³Ù²¹²Ô»å²¹°ù»åÌýFASP-S02) in quarter 1 2024 to 2025 was 97.9%. FA2 is collected 6 months (2 quarters) in arrears.

Quarter 1 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 1 2024 to 2025	132,714	135,584	97.9%

Region	Performance %
East of England	99.1%
London	93.9%
Midlands	98.7%
North East and Yorkshire	99.0%
North West	99.0%
South East	98.7%
South West	98.9%
England	97.9%

1.2 KPIÌý¹ó´¡3

There is no intention to publish FA3 (see ²õ³Ù²¹²Ô»å²¹°ù»åÌýFASP-S01) by individual maternity service.

1.3 KPI FA4: combined samples

FA4 (see ²õ³Ù²¹²Ô»å²¹°ù»åÌýFASP-SO6) was introduced in 2020 to 2021. New KPIs are not published in the first year of data collection. This time is used to improve the data quality and completeness, by revising the definition, adding clarity and / or setting thresholds as required.

In quarter 2 2024 to 2025, national performance of FA4 for inadequate combined samples was 3.5%. FA4 is a KPI where a lower performance is better.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	4,093	115,519	3.5%

Region	Performance %
East of England	2.7%
London	1.5%
Midlands	3.5%
North East and Yorkshire	6.9%
North West	3.1%
South East	4.6%
South West	2.5%
England	3.5%

1.4 KPI FA4: quadruple samples

FA4 (see ²õ³Ù²¹²Ô»å²¹°ù»åÌýFASP-S06) was introduced in 2020 to 2021. New KPIs are not published in the first year of data collection. This time is used to improve the data quality and completeness, by revising the definition, adding clarity and / or setting thresholds as required.

In quarter 2 2024 to 2025, national performance of FA4 for inadequate quadruple samples was 7.6%. FA4 is a KPI where a lower performance is better.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	960	12,674	7.6%

Region	Performance %
East of England	4.0%
London	3.2%
Midlands	6.8%
North East and Yorkshire	15.3%
North West	4.9%
South East	12.1%
South West	15.8%
England	7.6%

2. Infectious diseases in pregnancy screening

2.1 KPI ID1: HIV coverage

National performance of ID1 (see standard IDPS-S01) in quarter 2 2024 to 2025 was 99.8%.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	160,684	160,981	99.8%

Region	Performance %
East of England	99.8%
London	99.9%
Midlands	99.8%
North East and Yorkshire	99.8%
North West	99.8%
South East	99.8%
South West	99.6%
England	99.8%

2.2 KPI ID2: diagnosis/intervention: timely assessment of women with hepatitis B

National performance of ID2 (see standard IDPS-S06) in quarter 2 2024 to 2025 was 64.1%. The submission of data for ID2 has changed in 2023 to 2024 from maternity service self-reporting to the Integrated Screening Outcomes Surveillance Service (ISOSS) to improve consistency and accuracy of data returns. This has led to an expected reduction in performance as a result of more accurate data, and does not reflect a change in practice for screening providers.

In April 2023 the acceptable threshold changed from greater than or equal to 70% to greater than or equal to 75%. Due to the way the chart is currently produced, the acceptable threshold is presented as greater than or equal to 75% for all time periods.

ID2 is a small number KPI, therefore the data should be interpreted with caution.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	84	131	64.1%

Region	Performance %
East of England	78.6%
London	52.5%
Midlands	72.4%
North East and Yorkshire	66.7%
North West	70.0%
South East	62.5%
South West	60.0%
England	64.1%

2.3 KPI ID3: coverage: hepatitis B

National performance of ID3 (see standard IDPS-S02) in quarter 2 2024 to 2025 was 99.8%.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	160,683	160,978	99.8%

Region	Performance %
East of England	99.8%
London	99.9%
Midlands	99.8%
North East and Yorkshire	99.8%
North West	99.9%
South East	99.8%
South West	99.6%
England	99.8%

2.4 KPI ID4: coverage: syphilis

National performance of ID4 (see standard IDPS-S03) in quarter 2 2024 to 2025 was 99.8%.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	160,678	160,973	99.8%

Region	Performance %
East of England	99.8%
London	99.9%
Midlands	99.8%
North East and Yorkshire	99.8%
North West	99.9%
South East	99.9%
South West	99.6%
England	99.8%

3. Sickle cell and thalassaemia screening

3.1 KPI ST1: coverage: antenatal screening

National performance of ST1 (see standard SCT-S01) in quarter 2 2024 to 2025 was 99.8%.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	160,573	160,911	99.8%

Region	Performance %
East of England	99.8%
London	99.9%
Midlands	99.7%
North East and Yorkshire	99.8%
North West	99.8%
South East	99.8%
South West	99.6%
England	99.8%

3.2 KPI ST2: test: timeliness of antenatal screening

National performance of ST2 (see standard SCT-S02) in quarter 2 2024 to 2025 was 62.5%.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	102,138	163,304	62.5%

Region	Performance %
East of England	69.4%
London	56.4%
Midlands	54.4%
North East and Yorkshire	71.2%
North West	61.2%
South East	66.7%
South West	67.3%
England	62.5%

3.3 KPI ST3: test: completion of family origin questionnaire (FOQ)

National performance of ST3 (see standard SCT-S03) in quarter 2 2024 to 2025 was 96.9%.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	157,686	162,794	96.9%

Region	Performance %
East of England	98.1%
London	94.5%
Midlands	95.0%
North East and Yorkshire	98.4%
North West	97.7%
South East	98.5%
South West	98.6%
England	96.9%

3.4 KPI ST4a: referral: timely offer of prenatal diagnosis (PND) to women at risk of having an infant with sickle cell disease or thalassaemia

National performance of ST4a (see standard SCT-S05) in quarter 2 2024 to 2025 was 54.8%. Thresholds have not yet been set for this KPI.

ST4a is a small number KPI, therefore the data should be interpreted with caution.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	280	511	54.8%

Region	Performance %
East of England	83.3%
London	50.5%
Midlands	52.0%
North East and Yorkshire	72.7%
North West	30.3%
South East	59.6%
South West	33.3%
England	54.8%

3.5 KPI ST4b: referral: timely offer of prenatal diagnosis (PND) to couples at risk of having an infant with sickle cell disease or thalassaemia

National performance of ST4b (see standard SCT-S05) in quarter 2 2024 to 2025 was 68.1%. Thresholds have not yet been set for this KPI.

ST4b is a small number KPI, therefore the data should be interpreted with caution.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	239	351	68.1%

Region	Performance %
East of England	76.3%
London	70.7%
Midlands	61.0%
North East and Yorkshire	82.9%
North West	59.5%
South East	50.0%
South West	82.4%
England	68.1%

4. Newborn blood spot screening

4.1 KPI NB1: coverage of CCG responsibility at birth

National performance of NB1 (see standard NBS-S01a) in quarter 2 2024 to 2025 was 97.5%.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	137,756	141,289	97.5%

Region	Performance %
East of England	99.4%
London	96.7%
Midlands	97.9%
North East and Yorkshire	97.9%
North West	96.8%
South East	97.3%
South West	96.3%
England	97.5%

4.2 KPI NB2: test: quality of the blood spot sample

National performance of NB2 (see standard NBS-S06) in quarter 2 2024 to 2025 was 2.6%.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	3,788	145,735	2.6%

Region	Performance %
East of England	2.1%
London	2.4%
Midlands	2.7%
North East and Yorkshire	3.0%
North West	3.0%
South East	2.7%
South West	2.2%
England	2.6%

4.3 KPI NB4: coverage of movers in

National performance of NB4 (see standard NBS-S01b) in quarter 2 2024 to 2025 was 82.1%.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	11,155	13,589	82.1%

Region	Performance %
East of England	87.7%
London	71.6%
Midlands	82.9%
North East and Yorkshire	90.7%
North West	83.9%
South East	83.6%
South West	82.6%
England	82.1%

5. Newborn hearing screening

5.1 KPI NH1: coverage

National performance of NH1 (see ²õ³Ù²¹²Ô»å²¹°ù»åÌýNHSP-S01) in quarter 2 2024 to 2025 was 99.0%.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	152,623	154,206	99.0%

Region	Performance %
East of England	99.1%
London	98.8%
Midlands	99.2%
North East and Yorkshire	99.1%
North West	98.0%
South East	99.3%
South West	99.2%
England	99.0%

5.2 KPI NH2: diagnosis/intervention – time from screening outcome to attendance at an audiological assessment appointment

National performance of NH2 (see ²õ³Ù²¹²Ô»å²¹°ù»åÌýNHSP-S05) in quarter 2 2024 to 2025 was 91.4%.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	2,386	2,610	91.4%

Region	Performance %
East of England	92.2%
London	93.8%
Midlands	89.9%
North East and Yorkshire	90.3%
North West	87.8%
South East	94.5%
South West	96.9%
England	91.4%

6. Newborn and infant physical examination screening

6.1 KPI NP1: coverage

National performance of NP1 (see standard NIPE-S01) in quarter 2 2024 to 2025 was 96.4%.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	139,749	144,925	96.4%

Region	Performance %
East of England	96.8%
London	96.2%
Midlands	96.5%
North East and Yorkshire	96.2%
North West	96.4%
South East	96.1%
South West	97.4%
England	96.4%

6.2 KPI NP4: diagnosis/intervention – timeliness of hip clinical assessment or discharge

NP4 (see standard NIPE-S04) was introduced in 2024 to 2025.

In quarter 2 2024 to 2025, national performance of NP4 was 80.8%. As this quarter is the first time data is available for this KPI there is no chart.

Quarter 2 performance

Reporting period	Numerator	Denominator	Performance %
Quarter 2 2024 to 2025	10,207	12,634	80.8%

Region	Performance %
East of England	84.3%
London	77.8%
Midlands	83.3%
North East and Yorkshire	80.8%
North West	77.6%
South East	80.3%
South West	81.7%
England	80.8%